C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast (Q35184326)

7 August 2017

title

C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast (English)

1 reference

7 August 2017

Filiz Eren

1 reference

7 August 2017

Zerrin Calay

1 reference

7 August 2017

Haydar Durak

1 reference

7 August 2017

Bülent Eren

1 reference

7 August 2017

Nil Comunoğlu

1 reference

7 August 2017

Ovgü Aydin

1 reference

7 August 2017

publication date

1 February 2012

1 reference

Bosnian Journal of Basic Medical Sciences

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

41-50

1 reference

Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Ductal carcinoma in situ: a proposal for a new classification

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

c-erbB-2 expression in benign and malignant breast disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Follow-up of two treatment modalities for ductal cancer in situ of the breast

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

A prospective study of benign breast disease and the risk of breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Relation between component parts of fibrocystic disease complex and breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

Incidence of and treatment for ductal carcinoma in situ of the breast

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362418

bcl-2 expression in the spectrum of preinvasive breast lesions

27 September 2018

1 reference

12 December 2020

Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study

1 reference

12 December 2020

Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease

1 reference

12 December 2020

Risk factors for breast cancer in women with proliferative breast disease

1 reference

12 December 2020

The classification of ductal carcinoma in situ and its association with biological markers

1 reference

12 December 2020

A pathologic study of benign breast diseases in Tokyo and New York

1 reference

12 December 2020

The results of intraoperative consultations in 181 ductal carcinomas in situ of the breast

1 reference

12 December 2020

Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers

1 reference

12 December 2020

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

12 December 2020

Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?

1 reference

12 December 2020

Potential value of hormone receptor assay in carcinoma in situ of breast

1 reference

12 December 2020

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

12 December 2020

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1 reference

12 December 2020

The natural history of ductal carcinoma in situ. Implications for clinical decision making

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

Identifiers

DOI

10.17305/BJBMS.2012.2533

0 references

PMC publication ID

4362418

1 reference

7 August 2017

1 reference